Citadel Advisors - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 81 filers reported holding MEI PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2023$11,197
-43.8%
48,918
-40.2%
0.00%
Q4 2022$19,941
+17.3%
81,858
+84.8%
0.00%
Q3 2022$17,000
-82.5%
44,297
-72.3%
0.00%
Q2 2022$97,000
-86.4%
160,089
-86.5%
0.00%
Q1 2022$715,000
-75.3%
1,185,573
+9.6%
0.00%
-100.0%
Q4 2021$2,889,000
-6.1%
1,081,891
-3.0%
0.00%0.0%
Q3 2021$3,077,000
-37.8%
1,114,885
-35.8%
0.00%0.0%
Q2 2021$4,947,000
-39.6%
1,735,810
-27.3%
0.00%
-50.0%
Q1 2021$8,186,000
+29.8%
2,386,548
-0.1%
0.00%0.0%
Q4 2020$6,309,000
-28.3%
2,389,842
-15.2%
0.00%0.0%
Q3 2020$8,798,000
-24.7%
2,819,871
-0.3%
0.00%
-50.0%
Q2 2020$11,684,000
+578.5%
2,829,152
+164.5%
0.00%
+300.0%
Q1 2020$1,722,000
+1040.4%
1,069,585
+1670.0%
0.00%
Q2 2019$151,000
-27.8%
60,430
+24.6%
0.00%
Q3 2018$209,000
+54.8%
48,508
+40.7%
0.00%
Q2 2018$135,000
+400.0%
34,488
+167.3%
0.00%
Q1 2018$27,000
-20.6%
12,900
-20.7%
0.00%
Q4 2017$34,000
+78.9%
16,269
+49.3%
0.00%
Q3 2016$19,000
+11.8%
10,900
-17.3%
0.00%
Q1 2016$17,000
-57.5%
13,175
-47.9%
0.00%
Q4 2015$40,000
-13.0%
25,268
+134.4%
0.00%
Q4 2014$46,00010,7790.00%
Other shareholders
MEI PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 2,010,285$4902.42%
Anson Funds Management LP 10,617,959$2,586,5350.43%
NEA Management Company, LLC 8,533,072$2,078,6560.12%
Boxer Capital, LLC 2,913,091$709,6290.04%
Investmark Advisory Group LLC 136,000$33,1300.02%
CARLSON CAPITAL L P 1,180,000$287,4480.02%
Mesirow Financial Investment Management, Inc. 20,486$4,9900.02%
Artal Group S.A. 1,000,000$2440.01%
Annandale Capital, LLC 100,000$240.01%
ACADIAN ASSET MANAGEMENT LLC 4,758,364$1,1580.01%
View complete list of MEI PHARMA INC shareholders